Gilead Sciences said on Monday its experimental HIV treatment was found to be statistically non-inferior to its top-selling ...
Gilead Sciences said on Monday its experimental HIV treatment met the main goal and was found to be statistically ...
Today, we confront emerging threats from a range of respiratory viruses, insect-transmitted viruses, and viruses we have not ...
The U.S. commitment to ending HIV is shaken. For the first time, we didn't formally mark World AIDS Day. And Trump has cut ...
5d
Charlie Sheen claims experimental HIV drug was kept off market because 'it's a threat' to industry
Charlie Sheen reveals an experimental HIV drug that "never made it to market" and discusses his sobriety journey since 2017 ...
Stacker on MSN
Achieving lasting remission for HIV
Knowable Magazine reports on breakthroughs in HIV treatment; engineered antibodies show promise for long-term control, ...
Advancements in HIV/AIDS research, drug development and clinical practice since the 1980s have made it possible for people ...
News Medical on MSN
Researchers See Dramatic Drop in HIV-Infected Immune Cells in Patient After Cancer Treatment Received
Paper in @jclinicalinvest (bit.ly/497z6jo) by @HopkinsMedicine @JHUMed_ID finds patient living w/ #HIV has dramatic drop in ...
Sheen appeared on the “Today” show in 2015 and revealed his HIV status, saying doctors had detected the virus four years ...
Nurse practitioners discuss evidence-based cancer screening and risk-reduction strategies that primary care clinicians can implement for patients with HIV.
The Star Worldwide (English) on MSN
HIV gets lion’s share of Kenya-US health deal
In the agreement, the US will help countries build their own health systems over the next five years and stop being overly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback